VENUSREM — Venus Remedies Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSuper Stock

Annual income statement for Venus Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,393	5,481	5,986	5,555	6,014
Cost of Revenue
Gross Profit	1,650	2,073	2,132	2,123	2,301
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,393	5,062	5,696	5,271	5,678
Operating Profit	-0.058	419	290	284	337
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-80.4	486	364	379	446
Provision for Income Taxes
Net Income After Taxes	-100	618	407	266	285
Net Income Before Extraordinary Items
Net Income	-100	618	407	266	285
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-100	618	407	266	285
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3.46	37.7	30.9	19.9	21.3
Dividends per Share